CA2219758A1 - Compositions comprenant du bismuth et un ou plusieurs antimicrobiens, pour la prevention et le traitement de troubles gastro-intestinaux - Google Patents

Compositions comprenant du bismuth et un ou plusieurs antimicrobiens, pour la prevention et le traitement de troubles gastro-intestinaux Download PDF

Info

Publication number
CA2219758A1
CA2219758A1 CA002219758A CA2219758A CA2219758A1 CA 2219758 A1 CA2219758 A1 CA 2219758A1 CA 002219758 A CA002219758 A CA 002219758A CA 2219758 A CA2219758 A CA 2219758A CA 2219758 A1 CA2219758 A1 CA 2219758A1
Authority
CA
Canada
Prior art keywords
bismuth
milligrams
antimicrobials
days
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002219758A
Other languages
English (en)
Inventor
Jamesina Anne Fitzgerald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2219758A1 publication Critical patent/CA2219758A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des procédés de prévention et de traitement de troubles gastro-intestinaux provoqués ou transmis par un ou plusieurs protozoaires parasites chez l'homme et chez l'animal et consistant à administrer au sujet du bismuth, ainsi qu'un ou plusieurs antimicrobiens. Elle concerne également des compositions comprenant du bismuth, et un ou plusieurs antimicrobiens, pour la prévention ou le traitement de troubles gastro-intestinaux provoqués ou transmis par ou plusieurs protozoaires parasites chez l'homme et chez l'animal.
CA002219758A 1995-05-09 1996-05-08 Compositions comprenant du bismuth et un ou plusieurs antimicrobiens, pour la prevention et le traitement de troubles gastro-intestinaux Abandoned CA2219758A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43747595A 1995-05-09 1995-05-09
US437,475 1995-05-09

Publications (1)

Publication Number Publication Date
CA2219758A1 true CA2219758A1 (fr) 1996-11-14

Family

ID=23736610

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002219758A Abandoned CA2219758A1 (fr) 1995-05-09 1996-05-08 Compositions comprenant du bismuth et un ou plusieurs antimicrobiens, pour la prevention et le traitement de troubles gastro-intestinaux

Country Status (6)

Country Link
EP (1) EP0830135A1 (fr)
JP (1) JPH11504940A (fr)
AU (1) AU5733696A (fr)
CA (1) CA2219758A1 (fr)
PE (1) PE48297A1 (fr)
WO (1) WO1996035436A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2234581T3 (es) 1999-04-06 2005-07-01 Ethypharm Suspension farmaceutica bebible de ibuprofeno.
FR2791888B1 (fr) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques Suspension pharmaceutique buvable
CA2959414C (fr) 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole utilise dans le traitement d'une vaginose bacterienne

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222834A4 (fr) * 1985-04-18 1989-10-04 Borody Thomas J Traitement de la dyspepsie non ulcereuse avec des sels de bismuth.
ATE135582T1 (de) * 1985-06-13 1996-04-15 Barry James Marshall Verfahren und zusammensetzungen zur behandlung von gastrointestinalen störungen
JP2733849B2 (ja) * 1987-10-12 1998-03-30 ボロディー，ソーマス・ユリウス 胃腸障害治療のための改良された方法
DE59309771D1 (de) * 1993-05-11 1999-10-14 Spirig Ag Festes bismut- und amoxycillinhaltiges Arzneipräparat und seine Verwendung

Also Published As

Publication number Publication date
WO1996035436A1 (fr) 1996-11-14
JPH11504940A (ja) 1999-05-11
EP0830135A1 (fr) 1998-03-25
PE48297A1 (es) 1998-02-04
AU5733696A (en) 1996-11-29

Similar Documents

Publication Publication Date Title
US5256684A (en) Methods and compositions for the treatment of gastrointestinal disorders
EP0707854B1 (fr) Compositions pour le traitement des maladies gastrointestinales, contenant du bismuth et un agent antimicrobien
JP2733849B2 (ja) 胃腸障害治療のための改良された方法
Van Nieuwenhove et al. Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-α-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial
KR960016582B1 (ko) 위장장해의 치료 및 예방용 약제학적 조성물
Castro et al. Altered small bowel propulsion associated with parasitism
KR970007188B1 (ko) 위장장해 치료 조성물
World Health Organization The rational use of drugs in the management of acute diarrhoea in children
AU590578B2 (en) Treatment of non-ulcer dyspepsia with bismuth salts
CZ286202B6 (cs) Farmaceutický přípravek
EP1189622B1 (fr) Polymeres anioniques utilises comme liants de toxines ou agents antibacteriens
RU2116071C1 (ru) Лекарственные препараты, набор и способ лечения желудочно-кишечных заболеваний, вызываемых или опосредуемых заражением helicobaeter pylori
Borody et al. Helicobacter pylori Eradication with Doxycycline—Metronidazole—Bismuth Subcitrate Triple Therapy
CA2219758A1 (fr) Compositions comprenant du bismuth et un ou plusieurs antimicrobiens, pour la prevention et le traitement de troubles gastro-intestinaux
US6051604A (en) Methods and compositions for the prevention and treatment of gastrointestinal disorders
Beaty et al. Iatrogenic factors in infectious disease
O'Callaghan et al. Vincristine toxicity unrelated to dose.
CA2239423C (fr) Composition renfermant du bismuth et un ou plusieurs antimicrobiens pour la prevention et le traitement des troubles gastro-intestinaux
EP0830134A1 (fr) Compositions contenant du bismuth, pour la prevention et le traitement de troubles gastro-intestinaux
Robinson et al. Severe diarrhea secondary to propranolol
Alestig et al. Studies on the absorption and excretion of minocycline and a comparison with doxycycline
CA2239422C (fr) Compositions contenant du bismuth et destinees a la prevention et au traitement de troubles gastro-intestinaux
Johnson et al. Travelers’ diarrhea, new perspectives
Tolle et al. The evaluation and management of acute diarrhea.
Ozog et al. Diagnosis and treatment of cystinuria

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead